PT - JOURNAL ARTICLE AU - Omar J. Ahmed AU - Tibin T. John AU - Shyam K. Sudhakar AU - Ellen K.W. Brennan AU - Alcides Lorenzo Gonzalez AU - Jason S. Naftulin AU - Emad Eskandar AU - Joseph R. Madsen AU - G. Rees Cosgrove AU - Andrew S. Blum AU - N. Stevenson Potter AU - George A. Mashour AU - Leigh R. Hochberg AU - Sydney S. Cash TI - Two modes of inhibitory neuronal shutdown distinctly amplify seizures in humans AID - 10.1101/2020.10.09.20204206 DP - 2020 Jan 01 TA - medRxiv PG - 2020.10.09.20204206 4099 - http://medrxiv.org/content/early/2020/10/20/2020.10.09.20204206.short 4100 - http://medrxiv.org/content/early/2020/10/20/2020.10.09.20204206.full AB - Inhibitory neurons are critical for normal brain function but dysregulated in disorders such as epilepsy. At least two theories exist for how inhibition may acutely decrease during a seizure: hyperpolarization of fast-spiking (FS) inhibitory neurons by other inhibitory neurons, or depolarization block (DB) of FS neurons resulting in an inability to fire action potentials. Firing rate alone is unable to disambiguate these alternatives. Here, we show that human FS neurons can stop firing due to both hyperpolarization and DB within the same seizure. However, only DB of FS cells is associated with dramatic increases in local seizure amplitude, unobstructed traveling waves, and transient increases in excitatory neuronal firing. This result is independent of seizure etiology or focus. Computational models of DB reproduce the in vivo human biophysics. These methods enable intracellular decoding using only extracellular recordings in humans and explain the otherwise ambiguous inhibitory neuronal control of human seizures.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the American Epilepsy Society Junior Investigator Research Award, CURE Epilepsy Taking Flight Award, NINDS F32-NS083208 and University of Michigan Startup Funds (OJA), NIH R01-NS062092 (SSC) and NSF graduate student fellowships (TTJ & EKWB).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All human subjects were enrolled after informed consent was obtained and approval was granted by the Institutional Review Boards of Massachusetts General Hospital, Brigham & Womens Hospital and Rhode Island Hospital.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe seizure data that support the findings of this study are available on request from the authors. The data are not publicly available due to them containing information that could compromise research participant privacy/consent.